SQA
ALXN

Simon Quick Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Simon Quick Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-229
Closed -$26K – 573
2020
Q3 		$26K Sell
229
-206
-47% -$22.2K 0.01% 285
2020
Q2 		$49K Hold
435
– – 0.02% 192
2020
Q1 		$39K Buy
+435
New +$42.7K 0.01% 221
2019
Q1 		– Sell
-3
Closed – – 456
2018
Q4 		$0 Buy
+3
New +$355 ﹤0.01% 385
2017
Q4 		– Sell
-10,007
Closed -$1.4M – 613
2017
Q3 		$1.4M Hold
10,007
– – 0.51% 33
2017
Q2 		$1.22M Buy
+10,007
New +$1.16M 0.69% 27

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Simon Quick Advisors's ALXN Position: Q4 2020 in Review

Simon Quick Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 229 shares — an estimated $26K sold.

Simon Quick Advisors first reported a position in ALXN in Q2 2017 and held it in 6 quarters. The position peaked at $1.4M in Q3 2017. 827 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

  • Simon Quick Advisors reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Simon Quick Advisors sold 229 Alexion Pharmaceuticals shares in Q4 2020, an estimated $26K.
  • Simon Quick Advisors first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 6 quarters.
  • Simon Quick Advisors's Alexion Pharmaceuticals position peaked at $1.4M in Q3 2017.
  • 827 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on Simon Quick Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.